Cd Private Equity Fund Iii
- Short interest
- 0.00%
- as of 12 Dec 2022
- Reported shorts
- 1.4K
- Shares on issue
- 72.028M
Cd Private Equity Fund Iii (CD3) Short Interest
Cd Private Equity Fund Iii (ASX:CD3) had 0.00% of shares reported as short positions as of 12 Dec 2022, representing 1,378 shares. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4About Cd Private Equity Fund Iii
Cd Private Equity Fund Iii (CD3) is an ASX-listed Managed Investment Scheme providing investors with exposure to a portfolio of small-to-mid sized private investment funds and privately held companies, primarily in the US. The fund replicates the long-term private equity investment strategy of Cordish Private Ventures, offering side-by-side investment opportunities with the Cordish Family. Its objective is to achieve capital growth over a five to ten-year horizon by focusing on niche investment opportunities and operating businesses with proven cash flows.
Company profile →Cd Private Equity Fund Iii (ASX:CD3) has 0.00% of its shares on issue reported as short positions as of 12 Dec 2022, or about 1,378 shares. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Short interest
History & FAQ →Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.
Strategy fit
How each stock picker strategy reads CD3 today
- Zanger BreakoutWatchScore 17rank 1404 of 1942
- CAN SLIMNot a candidate
- Minervini Trend TemplateNot a candidate
- Crowded-Short BreakoutNot a candidate
- Quality compoundersNot a candidate
Prices to 14 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →
CD3 fundamentals
In the year to 31 Mar 2026, Cd Private Equity Fund Iii (ASX:CD3) recorded revenue of −A$696.7K and a net loss after tax of A$9.0M. A year earlier it recorded revenue of −A$171.2K and net profit after tax of A$18.6M. Return on equity −7.2% (FY). Figures are in AUD, the company's reporting currency; source: Yahoo Finance, as at 14 Oct 2026.
Full statements, ratios and filings are on the Financials tab. Not financial advice.
Latest CD3 news
All news- Net Tangible Asset Backing & Fund Update
asx · 13 Oct 2026
- CD Private Equity Fund III Announces August 2026 NTA of $1.45 Per Unit
kalkine · 14 Sept 2026
- Net Tangible Asset Backing & Fund Update
asx · 13 Sept 2026
Company details
website
address
Be the first to discuss CD3
Start a research thread or post the first pulse update